How to Decide If a GLP-1 Like Ozempic, Mounjaro or Compounded GLP-1 Is Right for You
Picking the right weight-loss injection is a balance of evidence, side-effect tolerance, price and personal health goals. This step-by-step guide makes the decision easier.
Ozempic (semaglutide), Mounjaro (tirzepatide) and their compounded cousins work by mimicking the GLP-1 hormone that tells your brain “I’m full,” slows stomach emptying and lowers blood sugar. If your body-mass index is ≥30 kg/m2 (or ≥27 with a weight-related condition such as PCOS or prediabetes), clinical trials show these injections can trim 15–21 % of body weight on average and improve metabolic markers. The best choice comes down to three factors: medical eligibility, risk tolerance for side effects, and out-of-pocket cost — all of which you can and should review in a shared decision visit with your healthcare provider.
- Tirzepatide 15 mg achieved roughly 21 % average weight loss in the SURMOUNT-1 study at 72 weeks, the highest seen in any obesity drug trial to date. [pubmed.ncbi.nlm.nih.gov]
- Compounded semaglutide or tirzepatide may cost as little as $225–$429 a month but lack FDA quality oversight and carry dosing-error warnings. [fda.gov]
- People with PCOS, type 2 diabetes, or BMI ≥40 derive the greatest metabolic benefit, while those with a history of medullary thyroid cancer should avoid GLP-1s.
- Most patients experience mild nausea that improves after four to six weeks; call your doctor immediately for severe vomiting or signs of pancreatitis.
What GLP-1 Medicines Are and How They Work
Glucagon-like peptide-1 receptor agonists (GLP-1 RAs) are injectable (and in one case oral) drugs that copy the gut hormone GLP-1. After you eat, natural GLP-1 tells the pancreas to release insulin, slows stomach emptying so you feel full longer, and sends satiety signals to the brain. Ozempic, Wegovy, Mounjaro and compounded GLP-1s extend that signal all week, which reduces appetite, calorie intake and — over months — weight.
Definition (60 words): A GLP-1 medicine is a once-weekly injection (or daily pill) that activates the GLP-1 receptor to lower blood sugar, decrease hunger and promote weight loss in adults with obesity, overweight, type 2 diabetes or polycystic ovary syndrome (PCOS). The class includes FDA-approved semaglutide and tirzepatide plus pharmacy-compounded versions when shortages occur.
Because the same pathway blunts glucagon, GLP-1s also reduce A1C by roughly 1.0–1.9 percentage points, which is why many patients use Ozempic or Mounjaro for dual diabetes and weight control.
Who Should Consider a GLP-1 Injection
The simplest eligibility yardstick is body-mass index: BMI ≥30 or ≥27 with a weight-related comorbidity meets FDA labeling. Yet real-world decisions layer on fertility goals, insurance rules, emotional readiness and cost.
BMI and comorbidities: PCOS, prediabetes, hypertension or obstructive sleep apnea strengthen the medical case. First-time GLP-1 users often start after diet and exercise alone hit a plateau.
Contraindications: Personal or family history of medullary thyroid cancer, multiple endocrine neoplasia 2, active gallbladder disease, severe GI disorders or pregnancy are reasons to skip or delay.
Patient preference: If weekly needles feel daunting, a daily pill version of semaglutide exists but insurance rarely covers it for weight loss.
How Much Weight Can You Lose — Trial Data at a Glance
Clinical trials show semaglutide and tirzepatide outperform every previous weight-loss pill or injection. Here’s what the numbers look like next to placebo.
| Drug & Dose | Average % Weight-Loss (Weeks) | Trial Name / n |
|---|---|---|
| Semaglutide 2.4 mg | −15 % (68 wks) | STEP-1 / 1,961 adults ([pubmed.ncbi.nlm.nih.gov](https://pubmed.ncbi.nlm.nih.gov/34192449/?utm_source=openai)) |
| Tirzepatide 15 mg | −21 % (72 wks) | SURMOUNT-1 / 2,539 adults ([pubmed.ncbi.nlm.nih.gov](https://pubmed.ncbi.nlm.nih.gov/35658024/?dopt=Abstract&utm_source=openai)) |
| Compounded Semaglutide† | −12–14 % (clinic series) | Real-world reports, no RCT |
| Placebo (lifestyle only) | −3 % | STEP & SURMOUNT control arms |
†Outcomes vary with pharmacy potency and dosing accuracy; no large randomized trial exists.
Beyond the scale, both drugs improved waist circumference, blood pressure and lipids. Tirzepatide showed a 79 % odds of achieving at least 5 % weight loss versus 34 % with semaglutide at standard doses. ([pubmed.ncbi.nlm.nih.gov](https://pubmed.ncbi.nlm.nih.gov/35658024/?dopt=Abstract&utm_source=openai))
Compounded vs FDA-Approved: Safety and Legal Differences
FDA-approved products guarantee potency and sterility; compounded versions do not. Compounding pharmacies may step in only when Ozempic, Wegovy or Mounjaro are officially on the FDA shortage list.
Quality risks: The FDA issued a 2024 alert about dosing errors in compounded semaglutide — some syringes contained 15 % less medication, others 20 % more. ([fda.gov](https://www.fda.gov/drugs/human-drug-compounding/compounding-risk-alerts?utm_source=openai))
Legal gray areas: As of May 2026 the agency has proposed excluding semaglutide and tirzepatide from the 503B bulks list, meaning large-scale outsourcing facilities could be barred from compounding them. ([fda.gov](https://www.fda.gov/news-events/press-announcements/fda-proposes-exclude-semaglutide-tirzepatide-and-liraglutide-503b-bulks-list?utm_source=openai))
That said, reputable 503A pharmacies can still prepare patient-specific scripts when shortages exist. Ask for a certificate of analysis, sterility testing and verification that they use the base form of the molecule, not unproven semaglutide salts. Semaglutide-compound and tirzepatide-compound pages list vetted pharmacies.
Cost & Access: Insurance, Coupons and Compounding
The sticker price of GLP-1s ranges from manageable to eye-watering depending on coverage.
| Product | Typical Cash Price / Month | With Rx.com Discount | Insurance Coverage Notes |
|---|---|---|---|
| Ozempic 0.5–1 mg | $927 | $746 | Often covered for diabetes, rarely for weight loss |
| Wegovy 2.4 mg | $1,349 | $1,121 | Coverage improving, prior auth needed |
| Mounjaro 5–15 mg | $1,011 | $823 | Diabetes indication only; off-label weight use cash |
| Compounded Semaglutide | $225 | $199 | Cash only; verify pharmacy quality |
| Compounded Tirzepatide | $429 | $391 | Cash only; verify pharmacy quality |
Ready to Compare Today’s Lowest GLP-1 Prices?
Enter your ZIP code and see real-time discounts before you fill your prescription.
Building a Shared Decision Plan With Your Provider
A five-point checklist keeps the conversation focused and time-efficient.
1. Clarify the goal: Is it 10 % weight loss, lower A1C, fertility improvement with PCOS, or all three?
2. Review current meds: Interactions are rare, but delayed gastric emptying can reduce absorption of oral contraceptives — your clinician may advise backup birth control.
3. Balance risk and benefit: Discuss GI side-effects, gallstone risk and rare events like pancreatitis versus the cardiovascular benefit shown in semaglutide’s SELECT trial (mean 20 % reduction in major CV events).
4. Plan titration: A slower schedule cuts nausea; follow our GLP-1 titration guide for details.
5. Budget check: Compare insurance copay, manufacturer coupons, true cost breakdown and compounded quotes before committing.
Should I start a GLP-1 now or wait?
Check the column that fits your situation:
✅ Start now
- BMI ≥35 with PCOS or type 2 diabetes uncontrolled
- Tried lifestyle + at least one oral med without success
- No personal/family thyroid cancer history
- Able to afford $199–$823 monthly after discounts
- Comfortable self-injecting once a week
🏥 Wait / reconsider
- Active gallbladder disease or pancreatitis history
- Planning pregnancy within the next 3 months
- Severe GI disorders or gastroparesis
- Unable to cover out-of-pocket costs even with discounts
- Unsure about long-term lifestyle commitment
🚨 When to Contact Your Healthcare Provider
Contact your doctor immediately if you experience any of the following:
- Persistent vomiting — risk of dehydration and electrolyte imbalance
- Severe abdominal pain — could signal pancreatitis or gallstones
- Vision changes or eye pain — possible diabetic retinopathy flare
- Signs of allergic reaction — rash, swelling, difficulty breathing
- Rapid heartbeat or dizziness — may indicate dehydration or hypoglycemia
- Dark urine or pale stools — potential liver or gallbladder issue
- Severely low blood sugar — especially if also on insulin or sulfonylurea
- Sudden mood changes — rarely, medicines can affect mental health
Scientific References
- Wilding J PH et al. Once-Weekly Semaglutide in Adults with Overweight or Obesity. N Engl J Med, 2021.
- Jastreboff AM et al. Tirzepatide Once Weekly for the Treatment of Obesity. N Engl J Med, 2022.
- American Diabetes Association. Pharmacologic Treatment of Obesity in Adults: Standards of Care in Overweight and Obesity, 2026.
- FDA. Dosing Errors Associated With Compounded Injectable Semaglutide Products, July 2024.
- FDA. Proposal to Exclude Semaglutide, Tirzepatide and Liraglutide From 503B Bulks List, April 2026.
- Wharton S et al. Achieving BMI <25 kg/m2 with Tirzepatide Reduced ASCVD Risk. Obesity, 2026.
Frequently Asked Questions
Is Ozempic the same drug as Wegovy for weight loss?
Yes and no. Both contain semaglutide, but Wegovy is FDA-approved for obesity at 2.4 mg weekly, while Ozempic tops out at 2 mg and is only approved for type 2 diabetes. Using Ozempic off-label for weight loss is legal but often not covered by insurance.
How long after stopping a GLP-1 will I regain weight?
Studies show about two-thirds of lost weight returns within 12 months of discontinuation unless lifestyle habits are intensified or another medication is started. Maintenance therapy or step-down dosing may help.
Can I take a GLP-1 if I have PCOS but not diabetes?
Probably. PCOS counts as a weight-related comorbidity under FDA labeling, so a BMI ≥27 is enough. GLP-1s often improve insulin resistance, menstrual regularity and androgen levels.
Are compounded GLP-1s legal in every U.S. state?
Yes when the branded product is on FDA’s shortage list and the pharmacy follows 503A compounding rules. Some states add stricter limits, so check your state board of pharmacy.
Do GLP-1 injections cause hair loss?
Rapid weight loss can trigger temporary telogen effluvium regardless of the drug used. Adequate protein, biotin supplementation and slower titration may reduce shedding.
What’s the best injection site for Mounjaro?
The abdomen at least two inches from the navel is easiest, but thigh or upper arm are also approved. Rotate sites weekly to avoid lumps.
Can I drink alcohol while on semaglutide?
Light to moderate alcohol is usually safe, but both alcohol and GLP-1s lower blood sugar, so monitor closely and limit high-calorie drinks that sabotage weight goals.
Take the Next Step Toward Your Healthier Weight
Connect with a licensed provider today, see if you qualify for Ozempic, Mounjaro or a compounded alternative, and lock in the best price before your next refill.